CDC Recommendations for Seasonal Maternal RSV Vaccination

The CDC and ACIP recommend the RSV vaccination (Pfizer Abrysvo) for pregnant people during 32–36 weeks gestation using seasonal administration to protect infants against RSV-associated lower respiratory tract disease (LRTD) after birth. In most of the continental United States, the RSV vaccine should be given to pregnant people from September 1 through January 31, regardless of year-to-year circulation, when infants would be born during increased RSV activity. Read the COCA newsletter.